Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New York Proton Center (NYPC) is a premier radiation oncology facility located in East Harlem, Manhattan, providing advanced proton beam therapy to patients with complex tumors. As the first proton center in New York State, it operates as a unique consortium between three leading healthcare institutions: Memorial Sloan Kettering Cancer Center, Montefiore Health System, and Mount Sinai Health System. The center utilizes cutting-edge Intensity-Modulated Proton Therapy (IMPT) with pencil-beam scanning to deliver highly precise radiation that minimizes damage to surrounding healthy tissue. NYPC is also a hub for clinical research, participating in numerous trials to advance the standard of care in radiation oncology. The facility features three treatment rooms equipped with 360-degree gantries and a dedicated research room. By combining clinical excellence with academic research, NYPC serves as a global leader in the field of proton radiation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Proton Center.